New Strong Sell Stocks for April 15th
CPAC, EPC and CHE have been added to the Zacks Rank #5 (Strong Sell) List on April 15, 2026.
Chemed Corporation (CHE) Presents at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Transcript
Chemed Corporation (CHE) Presents at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Transcript
CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash
Chemed slips 15% as Q4 earnings and revenue missed estimates, margins contracted, and the 2026 EPS outlook fell short of consensus.
Chemtrade Logistics Income Fund (CHE.UN:CA) Q4 2025 Earnings Call Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q4 2025 Earnings Call Transcript
Chemed Corporation (CHE) Q4 2025 Earnings Call Transcript
Chemed Corporation (CHE) Q4 2025 Earnings Call Transcript
Should Investors Hold Chemed Stock in Their Portfolio Now?
CHE shows growth momentum from VITAS and resilient Roto-Rooter results, but macro headwinds and competition continue to cloud its near-term outlook.
Chemed (CHE) Upgraded to Buy: Here's What You Should Know
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chemtrade Logistics Income Fund (CHE.UN:CA) Q3 2025 Earnings Call Transcript
Chemtrade Logistics Income Fund ( CHE.UN:CA ) Q3 2025 Earnings Call November 12, 2025 10:00 AM EST Company Participants Rohit Bhardwaj - VP of Finance & CFO Scott Rook - CEO, President & Trustee Conference Call Participants Nikolai Goroupitch Joel Jackson - BMO Capital Markets Equity Research Ben Isaacson - Scotiabank Global Banking and Markets, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to Chemtrade Logistics Income Fund Third Quarter 2025 Conference Call. [Operator Instructions] I would now like to turn the conference call over to Rohit Bhardwaj, Chief Financial Officer.
Chemed Corporation (CHE) Presents at UBS Global Healthcare Conference 2025 Transcript
Chemed Corporation ( CHE ) UBS Global Healthcare Conference 2025 November 11, 2025 2:00 PM EST Company Participants Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Kevin McNamara - CEO, President & Director Joel Wherley - CEO, President & Chief Operating Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division All right. Thanks, everyone.
Wall Street Analysts Predict a 32.69% Upside in Chemed (CHE): Here's What You Should Know
The mean of analysts' price targets for Chemed (CHE) points to a 32.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Chemed Corporation (CHE) Q3 2025 Earnings Call Transcript
Chemed Corporation ( CHE ) Q3 2025 Earnings Call October 29, 2025 10:00 AM EDT Company Participants Holley Schmidt Kevin McNamara - CEO, President & Director Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Joel Wherley - CEO, President & Chief Operating Officer Conference Call Participants Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Presentation Operator Good morning, and thank you for standing by. Welcome to the Chemed Corporation Third Quarter 2025 Earnings Conference Call.
CHE Stock Falls on Q3 Earnings and Revenue Miss, Margins Crash
Chemed's Q3 miss sends shares lower as shrinking margins and weaker EPS overshadow steady revenue gains from VITAS and Roto-Rooter.
